Author | Robert J. Motzer, MD | OncLive

Author | Robert J. Motzer, MD

Articles

Dr. Motzer on First-Line Treatment of Metastatic RCC

November 07, 2019

Video

Robert J. Motzer, MD, discusses the first-line treatment landscape of metastatic clear cell renal cell carcinoma.

Dr. Motzer on Nivolumab/Ipilimumab Activity in RCC

February 03, 2017

Video

Robert J. Motzer, MD, medical oncologist at Memorial Sloan Kettering Cancer Center, 2016 Giant of Cancer Care in Genitourinary Cancer, discusses the data seen thus far with nivolumab plus ipilimumab in the treatment of patients with renal cell carcinoma.

Dr. Motzer on the Milestone of Immunotherapy in RCC

January 27, 2017

Video

Robert J. Motzer, MD, medical oncologist at Memorial Sloan Kettering Cancer Center, 2016 Giant of Cancer Care in Genitourinary Cancer, discusses the explosion of immunotherapy in the landscape of renal cell carcinoma (RCC).

Dr. Motzer on Nivolumab Versus Everolimus in Renal Call Carcinoma

January 18, 2017

Video

Robert J. Motzer, MD, attending physician, Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, and professor of Medicine, Weill Medical College, Cornell University, discusses the FDA approval of nivolumab (Opdivo) versus everolimus (Afinitor) for patients with advanced renal cell carcinoma (RCC).

x